It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Results of clinical genomic testing must be reported in a clear, concise format to ensure they are understandable and interpretable. It is important laboratories are aware of the information which is essential to make sure the results are not open to misinterpretation. As genomic testing has continued to evolve over the past decade, the European Society of Human Genetics (ESHG) recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic) published in 2014 have been reviewed and updated to provide the genomic community with guidance on reporting unambiguous results.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Little France Crescent, GenQA, Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK (GRID:grid.418716.d) (ISNI:0000 0001 0709 1919)
2 Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge University Hospitals Genomic Laboratory, Cambridge, UK (GRID:grid.24029.3d) (ISNI:0000 0004 0383 8386)
3 University of Coimbra, Faculty of Medicine, Cytogenetics and Genomics Laboratory, iCBR/CIMAGO, Center for Innovative Biomedicine and Biotechnology, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342)
4 University of Leuven, Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884)
5 St James University Hospital, ERNDIM, Biochemical Genetics, Specialist Laboratory Medicine, Leeds, UK (GRID:grid.443984.6) (ISNI:0000 0000 8813 7132)
6 University Medical Centre Ljubljana, Clinical Institute of Genomic Medicine, Ljubljana, Slovenia (GRID:grid.29524.38) (ISNI:0000 0004 0571 7705)
7 Tartu University Hospital, Department of Clinical Genetics, United Laboratories, Tartu, Estonia (GRID:grid.412269.a) (ISNI:0000 0001 0585 7044); University of Tartu, Institute of Clinical Medicine, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661)
8 Oxford University Hospitals NHS Foundation Trust, Headley Way, GenQA, John Radcliffe Hospital, Oxford, United Kingdom (GRID:grid.410556.3) (ISNI:0000 0001 0440 1440)
9 Leiden University Medical Center, Department of Clinical Genetics, Leiden, the Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978)